This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Pierre Fabre Medicament, Université Paris-Sud 11. Active years: 2012.
Company Filing History:
1 out of 5,383 
1 out of 269 
1 out of 43 Years Active: 2012
Title: The Innovative Contributions of Danielle Bonnet-Delpon
Introduction
Danielle Bonnet-Delpon is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer therapy through her innovative research and development of pharmaceutical compounds. Her work focuses on the application of dimeric derivatives of artemisinin, which have shown promise in treating cancer.
Latest Patents
Danielle Bonnet-Delpon holds a patent for "Dimeric derivatives of artemisinin and application in anticancer therapy." This invention relates to dimeric derivatives of 10-trifluoromethylated artemisinin, which can be used in treating cancer. The patent also covers the preparation method of these compounds, which are essential for their application in pharmaceutical settings. She has 1 patent to her name.
Career Highlights
Throughout her career, Danielle has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Paris-Sud 11. Her research has contributed to advancements in cancer treatment, showcasing her dedication to improving patient outcomes through innovative therapies.
Collaborations
Danielle has collaborated with notable colleagues, including Constance Chollet and Céline Mordant. These partnerships have further enhanced her research efforts and have led to significant advancements in her field.
Conclusion
Danielle Bonnet-Delpon's work exemplifies the impact of innovation in the medical field, particularly in cancer therapy. Her contributions through her patent and collaborations highlight her commitment to advancing healthcare solutions.